Vidofludimus
Vidofludimus (SC12267, 4SC-101) is an orally active and potent dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of 134 nM for human DHODH. Vidofludimus calcium (IMU-838) is investigated as a potential treatment option for COVID-19. Phase 2.
| Trivial name | SC12267, 4SC-101 |
| Catalog Number | S7262 |
| CAS# | 717824-30-1 |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/vidofludimus.html |
| Additional Information | https://file.selleck.cn/downloads/struct/vidofludimus-chemical-structure-s7262.gif |
